Differential induction of donor-reactive Foxp3+ regulatory T cell via blockade of CD154 vs CD40
American Journal of Transplantation · 2024
DOI: 10.1016/j.ajt.2024.03.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Transplantation, 2024. Verfasst von Danya Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Emory Transplant Center and Department of Surgery, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Forkhead Transcription Factors, CD40 Antigens, CD40 Ligand. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, APC Europe.
Abstract (Originalsprache)
Recently published studies in both murine models and a meta-analysis of non-human primate renal transplant studies showed that anti-CD154 reagents conferred a significant survival advantage over CD40 blockers in both animal models and across multiple organs. Here we sought to compare the induction of donor-reactive forkhead box P3+-induced regulatory T cells (Foxp3+ iTreg) in mice treated with anti-CD154 versus anti-CD40 monoclonal antibodies (mAbs). Results indicated that while treatment with anti-CD154 mAb resulted in a significant increase in the frequency of donor-reactive CD4+ Foxp3+ iTreg following transplantation, treatment with anti-CD40 or Cd40 deficiency failed to recapitulate this result. Because we recently identified CD11b as an alternate receptor for CD154 during alloimmunity, we interrogated the role of CD154:CD11b interactions in the generation of Foxp3+ iTreg and found that blockade of CD11b in Cd40-/- recipients resulted in increased donor-reactive Foxp3+ iTreg as compared with CD40 deficiency alone. Mechanistically, CD154:CD11b inhibition decreased interleukin (IL)-1β from CD11b+ and CD11c+ dendritic cells, and blockade of IL-1β synergized with CD40 deficiency to promote Foxp3+ iTreg induction and prolong allograft survival. Taken together, these data provide a mechanistic basis for the observed inferiority of anti-CD40 blockers as compared with anti-CD154 mAb and illuminate an IL-1β-dependent mechanism by which CD154:CD11b interactions prevent the generation of donor-reactive Foxp3+ iTreg during transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emory Transplant Center and Department of Surgery, Emory University, Atlanta, Georgia, USA.
- Emory Transplant Center and Department of Surgery, Emory University, Atlanta, Georgia, USA. Electronic address: mandy.ford@emory.edu.
Förderung
- NIAID NIH HHS
- National Institutes of Health
- APC Europe
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Liu, D., Yao, H., Ferrer, I. R., & Ford, M. L. (2024). Differential induction of donor-reactive Foxp3+ regulatory T cell via blockade of CD154 vs CD40. American Journal of Transplantation. https://doi.org/10.1016/j.ajt.2024.03.033
Vancouver
Liu D, Yao H, Ferrer IR, Ford ML. Differential induction of donor-reactive Foxp3+ regulatory T cell via blockade of CD154 vs CD40. American Journal of Transplantation. 2024. doi:10.1016/j.ajt.2024.03.033
BibTeX
@article{Liu2024,
author = {Liu, Danya and Yao, Hongmin and Ferrer, Ivana R and Ford, Mandy L},
title = {Differential induction of donor-reactive Foxp3+ regulatory T cell via blockade of CD154 vs CD40},
journal = {American Journal of Transplantation},
year = {2024},
doi = {10.1016/j.ajt.2024.03.033}
}
EUVIMED